tibljТуберкулез и болезни легкихTuberculosis and Lung Diseases2075-12302542-1506Медицинские знания и технологии10.21292/2075-1230-2022-100-2-53-60tiblj-1617Research ArticleОБЗОРREVIEWВидеоконтролируемое лечение – инновационный метод мониторинга терапии туберкулеза в условиях ограниченных ресурсов системы здравоохраненияVideo Observed Treatment is an Innovative Method of Tuberculosis Treatment Observation in Resource-Limited Health Care Settingshttps://orcid.org/0000-0002-1219-2180ПавлюченковаН. А.PavlyuchenkovaN. A.

Павлюченкова Надежда Александровна - кандидат фармацевтических наук, доцент кафедры управления и экономики фармации.

214019, Смоленск, Крупской ул., д. 28

Nadezhda A. Pavlyuchenkova - Candidate of Pharmaceutical Sciences, Associate Professor of Department of Pharmacy Management and Economics.

28, Krupskoy St., Smolensk, 214019

paramonovanadezhda@gmail.comhttps://orcid.org/0000-0002-0637-7955ВасильеваИ. А.VasilyevaI. A.

Васильева Ирина Анатольевна - доктор медицинских наук, профессор, директор.

127473, Москва, ул. Достоевского, д. 4, к. 2. Тел.: 8 (495) 631-15-15

Irina A. Vasilyeva - Doctor of Medical Sciences, Professor, Director.

Build. 2, 4, Dostoevskiy St., Moscow, 127473. Phone: +7 (495) 631-15-15

nmrc@nmrc.ruhttps://orcid.org/0000-0001-6596-9777СамойловаА. Г.SamoylovaA. G.

Самойлова Анастасия Геннадьевна - доктор медицинских наук, первый заместитель директора.

127473, Москва, ул. Достоевского, д. 4, к. 2. Тел.: 8 (495) 631-15-15

Anastasiya G. Samoylova - Doctor of Medical Sciences, First Deputy Director.

Build. 2, 4, Dostoevskiy St., Moscow, 127473. Phone: +7 (495) 631-15-15

SamoylovaAG@nmrc.ruhttps://orcid.org/0000-0002-2292-1228ТюльковаТ. Е.TyulkovaT. E.

Тюлькова Татьяна Евгеньевна - доктор медицинских наук, руководитель отдела координации научных исследований.

127473, Москва, ул. Достоевского, д. 4, к. 2. Тел.: 8 (495) 631-15-15

Tatyana E. Tyulkova - Doctor of Medical Sciences, Head of Department for Research Coordination.

Build. 2, 4, Dostoevskiy St., Moscow, 127473. Phone: +7 (495) 631-15-15

tulkova@urniif.ruФГБОУ ВО Смоленский государственный медицинский университет МЗ РФРоссияSmolensk State Medical UniversityRussian FederationФГБУ Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний МЗ РФРоссияNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesRussian Federation20221403202210025360Copyright © Павлюченкова Н.А., Васильева И.А., Самойлова А.Г., Тюлькова Т.Е., 20222022Павлюченкова Н.А., Васильева И.А., Самойлова А.Г., Тюлькова Т.Е.Pavlyuchenkova N.A., Vasilyeva I.A., Samoylova A.G., Tyulkova T.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tibl-journal.com/jour/article/view/1617Цель исследования

Цель исследования: анализ возможностей видеоконтролируемой терапии (ВКТ) как одного из направлений мобильного здравоохранения для мониторинга процесса лечения больных туберкулезом, обоснование перспектив применения ВКТ как альтернативы непосредственно контролируемой терапии, в том числе в условиях ограниченных ресурсов здравоохранения.

Материалы и методы

Материалы и методы. Проведен поиск исследований из библиографических баз данных: MEDLINE/PubMed, EMBASE, LILACS, IMEMR и IMSEAR, а также clinicaltrials.gov. Отобрано 40 публикаций по применению видеоконтролируемой терапии туберкулеза за рубежом и в РФ. Изучены рекомендации Всемирной организации здравоохранения по применению цифровых технологий в терапии туберкулеза, в частности видеоконтролируемого лечения.

Результаты

Результаты. Определены преимущества видеоконтролируемой терапии туберкулеза, возможности реализации данного подхода в различных группах пациентов с учетом критериев включения и исключения с оценкой эффективности его применения (повышение приверженности к терапии, увеличение числа завершенных наблюдений, повышение ответственности пациента за заболевание и терапию, экономическая выгода для системы здравоохранения и пациента). Исследование предопределяет возможности реализации видеоконтролируемой терапии туберкулеза в Российской Федерации.

The objective of the study: to analyze the potential use of video observed therapy (VOT) as one of the fields of mobile health care for treatment of patients with tuberculosis, to substantiate prospects of using VOT as an alternative to directly observed therapy including settings with limited health care resources.

Subjects and Methods

Subjects and Methods. The relevant studies were searched for in the following bibliographic databases: MEDLINE/PubMed, EMBASE, LILACS, IMEMR and IMSEAR, and clinicaltrials.gov. 40 publications devoted to video observed treatment of tuberculosis abroad and in Russia were selected. The recommendations of the World Health Organization on the use of digital technology in tuberculosis treatment, in particular video observed treatment have been studied.

Results

Results. The article highlights the advantages of video observed treatment of tuberculosis, the possibility of implementing this approach in different groups of patients taking into account the inclusion and exclusion criteria, assessing effectiveness of its use (improved treatment adherence, higher number of completed observations, better responsibility of patients for the disease and therapy, economic benefits for the health system and the patient). The study speculates on the potential implementation of video observed therapy of tuberculosis in the Russian Federation.

туберкулезинновациимобильное здравоохранениевидеоконтролируемая терапияэффективностьвыгодаtuberculosisinnovationmobile healthvideo observed therapyefficiencybenefitReferencesЕлькина И. А., Саранчина С. В., Плохих Д. А. Опыт организации видеоконтролируемого лечения туберкулеза в г. Кемерово // Актуальные вопросы фтизиатрии: материалы межрегиональной научно-практической конференции, посвященной 75-летнему юбилею Кемеровского областного клинического фтизиопульмонологического медицинского центра. ГБУЗ КО КОКФПМЦ; ФГБОУ ВО КемГМУ МЗ России. Кемерово. – 2018. – С. 41-42.Elkina I.А., Saranchina S.V., Plokhikh D.А. The experience of video observed treatment of tuberculosis in Kemerovo. Aktualnyye voprosy ftiziatrii: materialy mezhregionalnoy nauchno-prakticheskoy konferentsii, posvyaschennoy 75-letnemu yubileyu Kemerovskogo oblastnogo klinicheskogo ftiziopulmonologicheskogo meditsinskogo tsentra. [Topical issues of phthisiology: Abst. Book of the Interregional Scientific Practical Conference dedicated to the 75th anniversary of the Kemerovo Regional Clinical Phthisiopulmonology Medical Center]. GBUZ KO KOKFPMTS; FGBOU VO KemGMU MZ Rossii Publ., Kemerovo, 2018, pp. 41-42. (In Russ.)Кадыров А. С., Мырзалиев Б. Б., Ахматов М. Б., Сулайманова М. И. Предварительные результаты пилотирования видео-контролируемого лечения для пациентов с туберкулезом в Кыргызской Республике // Здравоохранение Кыргызстана. – 2019. – № 1. – С. 68-72.Kadyrov А.S., Myrzaliev B.B., Аkhmatov M.B., Sulaymanova M.I. Preliminary results of pilot video observed treatment for patients with tuberculosis in the Kyrgyz Republic. Zdravookhranenie Kyrgyzstana, 2019, no. 1, pp. 68-72. (In Russ.)Карпов О. Э., Субботин С. А., Шишканов Д. В., Замятин М. Н. Цифровое здравоохранение. Необходимость и предпосылки // Врач и информационные технологии. – 2017. – № 3. – С. 6-22.Karpov O.E., Subbotin S.А., Shishkanov D.V., Zamyatin M.N. Digital health care. Necessity and prerequisites. Vrach I Informatsionnye Tekhnologii, 2017, no. 3, pp. 6-22. (In Russ.)Никитин П. В. Мурадянц А. А., Шостак Н. А. Мобильное здравоохранение: возможности, проблемы, перспективы // Клиницист. – 2015. – Т. 9, № 4. – С. 13-21.Nikitin P.V., Muradyants А.А., Shostak N.А. Mobile health care: possibilities, problems, perspectives. Klinitsist, 2015, vol. 9, no. 4, pp. 13-21. (In Russ.)Равильоне М. К., Коробицын А. А. Ликвидация туберкулеза – новая стратегия ВОЗ в эру целей устойчивого развития, вклад Российской Федерации // Туб. и болезни легких. – 2016. – Т. 94, № 11. – С. 7-15.Raviglione M.C. Korobitsin A.A. End TB – The new WHO strategy in the SDG era, and the contributions from the Russian Federation. Tuberculosis and Lung Diseases, 2016, vol. 94, no. 11, pp. 7-15. (In Russ.)Alipanah N., Jarlsberg L., Miller C., Linh N. N., Falzon D., Jaramillo E., Nahid P. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies // PLoS Med. – 2018. – Vol. 15, № 7. – P. e1002595. DOI: 10.1371/journal.pmed.1002595.Alipanah N., Jarlsberg L., Miller C., Linh N.N., Falzon D., Jaramillo E., Nahid P. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLos Med., 2018, vol. 15, no. 7, pp. e1002595. doi: 10.1371/journal.pmed.1002595.Bayer R., Wilkinson D. Directly observed therapy for tuberculosis: history of an idea // Lancet. – 1995. – Vol. 345, № 8964. – Р. 1545-1548. DOI: 10.1016/s0140-6736(95)91090-5.Bayer R., Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet, 1995, vol. 345, no. 8964, pp. 1545-1548. doi: 10.1016/s0140-6736(95)91090-5.Browne S. H., Umlauf A., Tucker A. J., Low J., Moser K., Gonzalez Garcia J., Peloquin C. A., Blaschke T., Vaida F., Benson C.A. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial // PLoS Med. – 2019. – Vol. 16, № 10. – Р. e1002891. DOI: 10.1371/journal.pmed.1002891.Browne S.H., Umlauf A., Tucker A.J., Low J., Moser K., Gonzalez Garcia J., Peloquin C.A., Blaschke T., Vaida F., Benson C.A. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial. PLos Med., 2019, vol. 16, no. 10, pp. e1002891. doi: 10.1371/journal.pmed.1002891.Chuck C., Robinson E., Macaraig M., Alexander M., Burzynski J. Enhancing management of tuberculosis treatment with video directly observed therapy in New York City // Int. J. Tuberc. Lung. Dis. – 2016. – Vol. 20, № 5. – P. 588-593. DOI: https://doi.org/10.5588/ijtld.15.0738.Chuck C., Robinson E., Macaraig M., Alexander M., Burzynski J. Enhancing management of tuberculosis treatment with video directly observed therapy in New York City. Int. J. Tuberc. Lung. Dis., 2016, vol. 20, no. 5, pp. 588-593. doi: https://doi.org/10.5588/ijtld.15.0738.Daley C. L. The global fight against tuberculosis // Thorac. Surg. Clin. – 2019. – Vol. 29, № 1. – P. 19-25. DOI: 10.1016/j.thorsurg.2018.09.010.Daley C.L. The global fight against tuberculosis. Thorac. Surg. Clin., 2019, vol. 29, no. 1, pp. 19-25. doi: 10.1016/j.thorsurg.2018.09.010.DeMaio J., Schwartz L., Cooley P. The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project // Clin. Infect. Dis. – 2001. – Vol. 33, № 12. – P. 2082-2084. DOI: 10.1086/324506.DeMaio J., Schwartz L., Cooley P. The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project. Clin. Infect. Dis., 2001, vol. 33, no. 12, pp. 2082-2084. doi: 10.1086/324506.European Centre for Disease Prevention and Control. Guidance on tuberculosis control in vulnerable and hard-to-reach populations. Stockholm: ECDC (2016). Available at: https://www.ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/TB-guidance-interventions-vulnerable-groups.pdf. [Accessed 4 January, 2020].European Centre for Disease Prevention and Control. Guidance on tuberculosis control in vulnerable and hard-to-reach populations. Stockholm: ECDC (2016). Available at: https://www.ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/TB-guidance-interventions-vulnerable-groups.pdf. (Accessed 4 January, 2020).Garfein R. S., Collins K., Muñoz F. Moser K., Cerecer-Callu P., Raab F., Rios P., Flick A., Zúñiga M. L., Cuevas-Mota J., Liang K., Rangel G., Burgos J. L., Rodwell T. C., Patrick K. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study // Int. J. Tuberc. Lung. Dis. – 2015. – Vol. 19, № 9. – P. 1057-1064. DOI: 10.5588/ijtld.14.0923.Garfein R.S., Collins K., Muñoz F. Moser K., Cerecer-Callu P., Raab F., Rios P., Flick A., Zúñiga M.L., Cuevas-Mota J., Liang K., Rangel G., Burgos J.L., Rodwell T.C., Patrick K. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study. Int. J. Tuberc. Lung. Dis., 2015, vol. 19, no. 9, pp. 1057-1064. doi: 10.5588/ijtld.14.0923.Garfein R. S., Doshi R. P. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support // J. Clin. Tuberc. Other Mycobact. Dis. – 2019. – Vol. 17. – P. 100098. DOI: 10.1016/j.jctube.2019.100098.Garfein R.S., Doshi R.P. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support. J. Clin. Tuberc. Other Mycobacter. Dis., 2019, vol. 17, pp. 100098. doi: 10.1016/j.jctube.2019.100098.Garfein R. S., Liu L., Cuevas-Mota J. Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA // Emerg. Infect. Dis. – 2018. – Vol. 24, № 10. – P. 1806-1815. DOI: 10.3201/eid2410.180459.Garfein R.S., Liu L., Cuevas-Mota J. Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA. Emerg. Infect. Dis., 2018, vol. 24, no. 10, pp. 1806-1815. doi: 10.3201/eid2410.180459.Goldfarb N. M. Improving subject compliance with smart pill bottles // J. Clin. Res. Best Pract. – 2007. – Vol. 8, № 3. – P. 1-5.Goldfarb N.M. Improving subject compliance with smart pill bottles. J. Clin. Res. Best Pract., 2007, vol. 8, no. 3, pp. 1-5.Guo P., Qiao W., Sun Y., Liu F., Wang C. Telemedicine technologies and tuberculosis management: a randomized controlled trial // Telemed. J. E-Health. – 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31794684. [Accessed 4 January, 2020]. DOI: 10.1089/tmj.2019.0190.Guo P., Qiao W., Sun Y., Liu F., Wang C. Telemedicine technologies and tuberculosis management: a randomized controlled trial. Telemed. J. E-Health, 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31794684. (Accessed 4 January, 2020). doi: 10.1089/tmj.2019.0190.Karumbi J., Garner P. Directly observed therapy for treating tuberculosis // Cochrane Database Syst. Rev. – 2015. – Issue 5. – Art. No.: CD003343. DOI:10.1002/14651858.CD003343.pub4.Karumbi J., Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst. Rev., 2015, issue 5, art. no. CD003343. doi:10.1002/14651858.CD003343.pub4.Khachtryan N. Video-DOT implementation in Armenia // 5th TB Symposium – Eastern Europe and Central Asia Ministry of Labour, Health and Social Affairs of Georgia and Médecins Sans Frontières 22-23 March, 2016, TBILISI, GEORGIA. Available at: http://www.tb-symposium.org/documents/en/6_IMPROVING_PATIENTS_EXPERIENCE/naira_khachatryan_video-dot_implementation.pdf. [Accessed 4 January, 2020].Khachtryan N. Video-DOT implementation in Armenia. 5th TB Symposium – Eastern Europe and Central Asia Ministry of Labour, Health and Social Affairs of Georgia and Médecins Sans Frontières 22-23 March, 2016, TBILISI, GEORGIA. Available at: http://www.tb-symposium.org/documents/en/6_IMPROVING_PATIENTS_EXPERIENCE/naira_khachatryan_video-dot_implementation.pdf. (Accessed 4 January, 2020).Krueger K., Ruby D., Cooley P., Montoya, B., Exarchos, A., Djojonegoro B. M., Field K. Videophone utilization as an alternative to directly observed therapy for tuberculosis // Int. J. Tuberc. Lung. Dis. – 2010. – Vol. 14, № 6. – P. 779-781.Krueger K., Ruby D., Cooley P., Montoya, B., Exarchos, A., Djojonegoro B.M., Field K. Videophone utilization as an alternative to directly observed therapy for tuberculosis. Int. J. Tuberc. Lung. Dis., 2010, vol. 14, no. 6, pp. 779-781.Kumar A. A., De Costa A., Das A., Srinivasa G., D'Souza G., Rodrigues R. Mobile health for tuberculosis management in South India: Is video-based directly observed treatment an acceptable alternative? // JMIR Mhealth Uhealth. – 2019. – Vol. 7, № 4. – P. e11687. DOI: 10.2196/11687.Kumar A.A., De Costa A., Das A., Srinivasa G., D'Souza G., Rodrigues R. Mobile health for tuberculosis management in South India: Is video-based directly observed treatment an acceptable alternative? JMIR Mhealth Uhealth., 2019, vol. 7, no. 4, pp. e11687. doi: 10.2196/11687.Lesnic E., Osipov T., Malic A. Eligilibility criteria for video-observed anti-tuberculosis treatment at patients from Chisinau // The Moldovan Med. J. – 2019. – Vol. 62, № 4. – P. 14-20. DOI: 10.5281/zenodo.3556469.Lesnic E., Osipov T., Malic A. Eligilibility criteria for video-observed anti-tuberculosis treatment at patients from Chisinau. The Moldovan Med. J., 2019, vol. 62, no. 4, pp. 14-20. doi: 10.5281/zenodo.3556469.Mirsaeidi M., Farshidpour M., Banks-Tripp D., Hashmi S., Kujoth C., Schraufnagel D. Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective // Eur. Respir. J. – 2015. – Vol. 46, № 3. – P. 871-874. DOI: 10.1183/09031936.00011015.Mirsaeidi M., Farshidpour M., Banks-Tripp D., Hashmi S., Kujoth C., Schraufnagel D. Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective. Eur. Respir. J., 2015, vol. 46, no. 3, pp. 871-874. doi: 10.1183/09031936.00011015.Nguyen T. A., Pham M. T., Nguyen T. L., Nguyen V. N., Pham D. C., Nguyen B. H., Fox G. J. Video directly observed therapy to support adherence with treatment for tuberculosis in Vietnam: A prospective cohort study // Int. J. Infect. Dis. – 2017. – Vol. 65. – P. 85-89. DOI: 10.1016/j.ijid.2017.09.029.Nguyen T.A., Pham M.T., Nguyen T.L., Nguyen V.N., Pham D.C., Nguyen B.H., Fox G.J. Video directly observed therapy to support adherence with treatment for tuberculosis in Vietnam: A prospective cohort study. Int. J. Infect. Dis., 2017, vol. 65, pp. 85-89. doi: 10.1016/j.ijid.2017.09.029.Ngwatu B. K., Nsengiyumva N. P., Oxlade O., Mappin-Kasirer B., Nguyen N. L., Jaramillo E., Falzon D., Schwartzman K. The impact of digital health technologies on tuberculosis treatment: a systematic review // Eur. Respir. J. – 2018. – Vol. 51, № 1. – P. 1701596. DOI: 10.1183/13993003.01596-2017.Ngwatu B.K., Nsengiyumva N.P., Oxlade O., Mappin-Kasirer B., Nguyen N.L., Jaramillo E., Falzon D., Schwartzman K. The impact of digital health technologies on tuberculosis treatment: a systematic review. Eur. Respir. J., 2018, vol. 51, no. 1, pp. 1701596. doi: 10.1183/13993003.01596-2017.Olano-Soler H., Thomas D., Joglar O. Notes from the Field: Use of Asynchronous video directly observed therapy for treatment of tuberculosis and latent tuberculosis infection in a long-term – care facility ‒ Puerto Rico, 2016-2017 // MMWR Morb. Mortal Wkly Rep. – 2017. – Vol. 66, № 50. – P. 1386-1387. DOI: 10.15585/mmwr.mm6650a5.Olano-Soler H., Thomas D., Joglar O. Notes from the Field: Use of Asynchronous video directly observed therapy for treatment of tuberculosis and latent tuberculosis infection in a long-term – care facility ‒ Puerto Rico, 2016–2017. MMWR Morb. Mortal Wkly Rep., 2017, vol. 66, no. 50, pp. 1386-1387. doi: 10.15585/mmwr.mm6650a5.Pettit A. C., Jenkins C. A., Blevins Peratikos M. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries // J. Int. AIDS Soc. – 2019. – Vol. 22, № 12. – P. e25423. DOI: 10.1002/jia2.25423.Pettit A.C., Jenkins C.A., Blevins Peratikos M. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. J. Int. AIDS Soc., 2019, vol. 22, no. 12, pp. e25423. doi: 10.1002/jia2.25423.Sagbakken M., Bjune G. A., Frich J. C. Humiliation or care? A qualitative study of patients' and health professionals' experiences with tuberculosis treatment in Norway // Scand. J. Caring Sci. – 2012. – Vol. 26, № 2. – P. 313-23. DOI: 10.1111/j.1471-6712.2011.00935.x.Sagbakken M., Bjune G.A., Frich J.C. Humiliation or care? A qualitative study of patients' and health professionals' experiences with tuberculosis treatment in Norway. Scand. J. Caring Sci., 2012, vol. 26, no. 2, pp. 313-23. doi: 10.1111/j.1471-6712.2011.00935.x.Seiguer J. D S., Rios K., Townsend K. Video DOT Implementation in Maryland: Outcomes & Opportunities. Available at: https://phpa.health.maryland.gov/OIDPCS/CTBCP/CTBCPDocuments/2017%20Annual%20Update/VideoDOT%20(1).pdf. [Accessed 4 January, 2020].Seiguer J. D S., Rios K., Townsend K. Video DOT Implementation in Maryland: Outcomes & Opportunities. Available at: https://phpa.health.maryland.gov/OIDPCS/CTBCP/CTBCPDocuments/2017%20Annual%20Update/VideoDOT%20(1).pdf. (Accessed 4 January, 2020).Sinkou H., Hurevich H., Rusovich V., Zhylevicet L., Falzon D., De Colombani P., Dadu А., Dara M., Story А., Skrahina А. Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience // Eur. Respir. J. – 2017. – Vol. 49, № 3. – Р. 1602049. https://doi.org/10.1183/13993003.02049-2016.Sinkou H., Hurevich H., Rusovich V., Zhylevicet L., Falzon D., De Colombani P., Dadu А., Dara M., Story А., Skrahina А. Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience. Eur. Respir. J., 2017, vol. 49, no. 3, pp. 1602049. https://doi.org/10.1183/13993003.02049-2016.Story A., Aldridge R. W., Smith C. M., Garber E., Hall J., Ferenando G., Possas L., Hemming S., Wurie F., Luchenski S., Abubakar I., McHugh T. D., White P. J, Watson J. M., Lipman M., Garfein R., Hayward A. C. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial // Lancet. – 2019. – Vol. 393, № 10177. – P. 1216-1224. DOI: 10.1016/S0140-6736(18)32993-3.Story A., Aldridge R.W., Smith C.M., Garber E., Hall J., Ferenando G., Possas L., Hemming S., Wurie F., Luchenski S., Abubakar I., McHugh T.D., White P.J, Watson J.M., Lipman M., Garfein R., Hayward A.C. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial. Lancet, 2019, vol. 393, no. 10177, pp. 1216-1224. doi: 10.1016/S0140-6736(18)32993-3.Technology Options for Video Directly Observed Therapy (VDOT) MHD. Available at: https://www.health.state.mn.us/diseases/tb/lph/vdot/techoptions.pdf. [Accessed 4 January, 2020].Technology Options for Video Directly Observed Therapy (VDOT) MHD. Available at: https://www.health.state.mn.us/diseases/tb/lph/vdot/techoptions.pdf. (Accessed 4 January, 2020).Wade V. A., Karnon J., Eliott J. A., Hiller J. E. Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation // PLoS One. – 2012. – Vol. 7, № 11. – P. e50155. DOI: 10.1371/journal.pone.0050155.Wade V.A., Karnon J., Eliott J.A., Hiller J.E. Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation. PLoS One, 2012, vol. 7, no. 11, pp. e50155. doi: 10.1371/journal.pone.0050155.World Health Organization. Digital health for the end TB strategy: an agenda for action (2015). Available at: https://www.who.int/tb/areas-of-work/digital-health/Digital_health_EndTBstrategy.pdf. [Accessed 4 January, 2020].World Health Organization. Digital health for the end TB strategy: an agenda for action (2015). Available at: https://www.who.int/tb/areas-of-work/digital-health/Digital_health_EndTBstrategy.pdf. (Accessed 4 January, 2020).World Health Organization. From innovation to implementation – eHealth in the WHO European Region (2016). Available at: http://www.euro.who.int/__data/assets/pdf_file/0012/302331/From-Innovation-to-Implementation-eHealth-Report-EU.pdf. [Accessed 4 January, 2020].World Health Organization. From innovation to implementation – eHealth in the WHO European Region (2016). Available at: http://www.euro.who.int/__data/assets/pdf_file/0012/302331/From-Innovation-to-Implementation-eHealth-Report-EU.pdf. (Accessed 4 January, 2020).World Health Organization. Global tuberculosis report 2019. Licence: CC BY-NC-SA 3.0 IGO (2019). Available at: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf. [Accessed 4 January, 2020].World Health Organization. Global tuberculosis report 2019. Licence: CC BY-NC-SA 3.0 IGO (2019). Available at: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf. (Accessed 4 January, 2020).World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Available at: https://apps.who.int/iris/bitstream/handle/10665/255052/9789241550000-eng.pdf?sequence=1. [Accessed 4 January, 2020].World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Available at: https://apps.who.int/iris/bitstream/handle/10665/255052/9789241550000-eng.pdf?sequence=1. (Accessed 4 January, 2020).World Health Organization. mHealth: new horizons for health through mobile technologies: second global survey on eHealth (2013). Available at: https://extranet.who.int/iris/restricted/bitstream/handle/10665/87688/9789244564257_rus.pdf?sequence=1&isAllowed=y. [Accessed 4 January, 2020].World Health Organization. mHealth: new horizons for health through mobile technologies: second global survey on eHealth (2013). Available at: https://extranet.who.int/iris/restricted/bitstream/handle/10665/87688/9789244564257_rus.pdf?sequence=1&isAllowed=y. (Accessed 4 January, 2020).World Health Organization. The END TB Strategy (2014). Available at: https://www.who.int/tb/strategy/End_TB_Strategy.pdf. [Accessed 4 January, 2020].World Health Organization. The END TB Strategy (2014). Available at: https://www.who.int/tb/strategy/End_TB_Strategy.pdf. (Accessed 4 January, 2020).World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment (2019). Available at: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf. [Accessed 4 January, 2020].World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment (2019). Available at: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf. (Accessed 4 January, 2020).

The authors declare that there are no conflicts of interest present.